Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2000
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/28/2000CN1053831C External application powder for eliminating numbness
06/28/2000CN1053812C Stasis reducing liquor
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080762 Having the patient inhale an aerosolized amount of raloxifene (hydrochloride) through the patient's mouth or nose into the lungs; aerosols; postmenopausal syndrome; osteoporosis
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000US6080739 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
06/27/2000US6080721 Pulmonary delivery of active fragments of parathyroid hormone
06/27/2000US6080720 Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)
06/27/2000US6080579 Method for producing human intervertebral disc cells
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036104A1 Pancreatic polypeptide zsig66
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035917A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035867A1 Novel ligands of nuclear receptor
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035436A2 Treatment of arthritis with mek inhibitors
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000015244A3 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355299A1 Novel ligands of nuclear receptor
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2355039A1 Pancreatic polypeptide zsig66
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354510A1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2353897A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
06/22/2000CA2346448A1 Treatment of arthritis with mek inhibitors
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/21/2000EP1009770A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009752A1 Novel molecules of the tango-77 related protein family and uses thereof
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009736A1 Malonic acid based matrix metalloproteinase inhibitors
06/21/2000EP1009444A2 Compositions and methods for treating arthritis utilizing gene therapy
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000CN1257477A Metalloproteinase inhibitors
06/21/2000CN1053589C Chinese patent medicine for treating bisyndrome
06/21/2000CN1053568C Herbal medicinal healthful beautifying products
06/20/2000US6077873 Steroid compounds having contraceptive and anti-osteoporosis activity
06/20/2000US6077872 Use of calcium L-threonate in preventing, inhibiting and curing osteoporosis and rickets
06/20/2000US6077864 Cyclic sulfone derivatives
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/20/2000CA2001618C Gestodene-containing agent for transdermal administration
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000034281A1 Methotrexate derivatives
06/15/2000WO2000034254A1 Novel compounds
06/15/2000WO2000033849A1 Use of ibandronate for promoting osseointegration of endoprostheses
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000033837A2 Myt1 kinase inhibitors
06/15/2000WO2000033667A2 Bioflavonoids, anthocyanins and phenol compounds from cherries as antioxidants
06/15/2000WO2000023618A8 Polymorphism in a tgf-beta gene correlated to osteoporosis
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
06/15/2000WO2000005254A3 Novel peptides for use in immunotherapy of autoimmune diseases
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2353839A1 Methotrexate derivatives
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/14/2000EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K
06/14/2000EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems
06/14/2000EP1007632A1 Isolation of bone and cartilage precursor cells
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007547A1 Peptides comprising a t-cell epitope specific to collagen ii
06/14/2000EP1007545A2 Cyclopeptide derivatives as adhesion inhibitors
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007505A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
06/14/2000EP1007096A1 Arginine silicate inositol complex and use thereof
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007076A1 Method of antagonizing the human src sh2 domain
06/14/2000EP1007072A1 Glial cell line-derived neurotrophic factor receptors
06/14/2000EP1007063A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells
06/14/2000EP1007054A1 Liquid alendronate formulations
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007026A1 Integrin antagonists
1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 820